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Blood-feeding parasites, including schistosomes, hook-
worms, and malaria parasites, employ aspartic pro-
teases to make initial or early cleavages in ingested host
hemoglobin. To better understand the substrate affinity
of these aspartic proteases, sequences were aligned with
and/or three-dimensional, molecular models were con-
structed of the cathepsin D-like aspartic proteases of
schistosomes and hookworms and of plasmepsins of
Plasmodium falciparum and Plasmodium vivax, using
the structure of human cathepsin D bound to the inhib-
itor pepstatin as the template. The catalytic subsites S5
through S4 were determined for the modeled parasite
proteases. Subsequently, the crystal structure of mouse
renin complexed with the nonapeptidyl inhibitor t-bu-
tyl-CO-His-Pro-Phe-His-Leu [CHOHCH2]Leu-Tyr-Tyr-Ser-
NH2 (CH-66) was used to build homology models of the
hemoglobin-degrading peptidases docked with a series of
octapeptide substrates. The modeled octapeptides in-
cluded representative sites in hemoglobin known to be
cleaved by both Schistosoma japonicum cathepsin D and
human cathepsin D, as well as sites cleaved by one but not
the other of these enzymes. The peptidase-octapeptide
substrate models revealed that differences in cleavage
sites were generally attributable to the influence of a
single amino acid change among the P5 to P4 residues
that would either enhance or diminish the enzymatic af-
finity. The difference in cleavage sites appeared to be
more profound than might be expected from sequence
differences in the enzymes and hemoglobins. The findings
support the notion that selective inhibitors of the hemo-
globin-degrading peptidases of blood-feeding parasites at
large could be developed as novel anti-parasitic agents.
Blood flukes, hookworms, and the malaria parasites are
among the most important pathogens of humans in terms of
both numbers of people infected and the consequent morbidity
and mortality (1). Although phylogenetically unrelated, these
parasites all share the same food source; they are obligate blood
feeders, or hematophages. Hb from ingested or parasitized
erythrocytes is their major source of exogenous amino acids for
growth, development, and reproduction; the Hb, a 64-kDa
tetrameric polypeptide, is comprehensively catabolized by par-
asite enzymes to free amino acids or small peptides. Intrigu-
ingly, all these parasites appear to employ cathepsin D-like
aspartic proteases to make initial or early cleavages in the Hb
substrate (2–4).
The vertebrate endopeptidase, cathepsin D (EC 3.4.23.5), is a
member of the aspartic protease category of hydrolases, which
also includes renin, pepsin, chymosin, cathepsin E, HIV1 pro-
tease, and several other enzymes (5, 6). Cathepsin D is ex-
pressed in a diverse range of mammalian cells and tissues and
is located predominantly in lysosomes (6). The molecule com-
prises two rather similar lobes, each incorporating a homolo-
gous Asp-Thr-Gly catalytic site motif, with the substrate bind-
ing groove located between these lobes. In aspartic proteases
generally, the nucleophile that attacks the scissile bond of the
substrate is an activated water molecule held in position by
side chains of the two active-site aspartic acids (5). Well defined
S4, S3, S2, S1, S1, S2, S3, and S4 subsite pockets for the
amino acid side chains of the substrate (5) are additional hall-
marks of these enzymes. A peptide analogue of microbial ori-
gin, pepstatin, is the definitive, general inhibitor of aspartic
proteases (7). In general, human cathepsin D is specific for
hydrophobic patches in proteins, with an ostensibly anomalous,
additional preference for glutamate in the P2 position (8–11).
An improved understanding of the substrate affinity of ca-
thepsin D-like proteases of blood-feeding parasites for Hb could
facilitate the development of novel anti-parasite inhibitors. To
this end, sequences or models of the cathepsin D-like aspartic
proteases of schistosomes and hookworms and of plasmepsins
of Plasmodium falciparum and Plasmodium vivax (PDB file
1QS8) were aligned with and/or three-dimensional, molecular
models were constructed, using the structure of human cathep-
sin D bound to pepstatin (1LYB) (12) as the template. Subse-
quently, the crystal structure of the peptidic inhibitor CH-66
complexed with mouse renin (1SMR) (13) was used to build
homology models of octapeptide substrates. The molecular
models were then used to examine the similarities and differ-
ences among known substrate cleavage sites in mammalian Hb
reported previously for the cathepsin D of Schistosoma japoni-
cum (4) and for human cathepsin D (11). The models revealed
that the difference in cleavage sites was due, in general, to a
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single amino acid alteration in the cleavage site (P4-P4) that
either enhances or diminishes the enzymatic activity.
EXPERIMENTAL PROCEDURES
Molecular Models of Cathepsin D-like Peptidases—Molecular model-
ing of the mature forms of the target aspartic proteases was carried out
on a Silicon Graphics work station using the Insight II software pack-
age from Molecular Simulations Inc. (San Diego, CA), as described
previously for several papain-like, cysteine proteases (14–16) and the
Swiss Model server. Models were viewed using Swiss PDBViewer. The
Insight II module, Homology, was used for the homology modeling.
Homology operates by copying the backbone atoms and -carbons from
the template molecule to the model and adding the new side chains.
Epitopes corresponding to -helix or -sheet in the template are as-
signed coordinates as structurally conserved regions, whereas other
regions are assigned coordinates as designated loops. The Loop Search
function was used to find suitable loops, from protein structures in the
PDB data base, which have the correct number of residues and distance
to bridge and in which the adjacent residues have the appropriate
conformations. Molecular models of the cathepsin D-like enzymes of the
blood flukes, S. japonicum (17) and Schistosoma mansoni (18), the
hookworm, Ancylostoma caninum (19), and plasmepsins I and II of P.
falciparum (20, 21) were built using the Homology module. The crystal
structure of human cathepsin D complexed with the inhibitor pepstatin,
PDB number ILYB (12), was used as the template (12). In addition, the
crystal structure of P. vivax plasmepsin complexed with pepstatin
(1QS8) was compared and contrasted with these models. Construction
of the homology models was based on previously determined sequence
alignments (12, 13, 17–19) but refined according to known secondary
structure. In the sequence alignments (shown below under “Results”;
see Fig. 1), residues that have side chains participating in substrate
binding pockets are indicated as the S5 to S4 subsites, respectively. In
the case of the schistosome and hookworm proteases, the COOH-termi-
nal domain extensions, which are 40 amino acid residues in length
(17–19), were omitted, because they could not be modeled in this way.
These proteases have three loops that differ from human cathepsin D,
including the latter’s cleaved hairpin loop, and the Loop Search function
was used to assign possible coordinates for the loops of the Schistosoma
cathepsin D proteases. The hookworm enzyme has an additional, un-
usual feature, two small loops, both of which are closed with disulfide
bonds, Cys92-Cys97 and Cys210-Cys217. Although the function of the
loops has not yet been determined, they do not appear to be structurally
important for catalysis. A homology model was also built of human
cathepsin D, based on itself, with the residues in the hairpin loop
deleted and replaced by a single glycine. This was done so that docking
with substrate peptides could be carried out similarly with all the other
proteases. In each case, the model was minimized to a root mean square
deviation of 0.000001, employing conjugate gradients using the Dis-
cover module of Insight II. Subsequently, the accuracy and validity of
the models was tested with the Profiles 3D module of Insight II, which
performs Eisenberg analysis (22).
Homology Models of Peptidase-Octapeptide Substrate Complexes—The
crystal structure of mouse renin complexed with the peptidic inhibitor
CH-66 (1SMR) (13) was used to build homology models of octapeptide
substrates within the catalytic clefts of S. japonicum cathepsin D, human
cathepsin D, and several other peptidases for which three-dimensional
homology models had been constructed. CH-66 is t-butyl-CO-His-Pro-Phe-
His-Leu[CHOHCH2]Leu-Tyr-Tyr-Ser-NH2, and the complex of CH-66
within the active site groove of mouse renin is an informative example,
with regard to the proteases and substrates targeted in this study, of an
extended peptide (P5 to P4) analogue bound to an archetypal aspartic
protease. It was anticipated that this complex would indicate subsite
binding pockets in human cathepsin D and homologous aspartic pro-
teases. Loop Search was used to replace the P1 and P1 isostere residues
of the inhibitor with an extended dipeptide and to assign coordinates to
the P1 and P1 residues.
The core and key substrate binding residues of mouse renin and
human cathepsin D were superimposed using the -carbons so that the
peptidase and substrate models were in the same space coordinates to
conserve the pattern of hydrogen bonding between the enzyme and the
backbone peptide bonds of the substrate. For the mouse reninCH-66
complex, the protease residues forming hydrogen bonds with the main
chain of the inhibitor are Gly37, His79, Ser80, Gly81, Asp220, Gly222,
Ser219, Ser222, and Thr200, whereas Asp35 and Asp220 are the catalytic
dyad of aspartic acids (numbering according to Fig. 1) (13). Notably,
these are consistent with the hydrogen bonding between human renin
and the inhibitor CP-85339 (13). The backbone atoms of human cathep-
sin D and mouse renin are not completely identical; differences in the
conformations have been noted for the S3, S2, and S3 pockets (12, 13).
These differences produce renin subsite pockets that are less open,
giving rise to the narrow specificity of this enzyme. Renin also has a
higher degree of secondary structure, with some longer stretches of
-helix and -sheet. Nonetheless, the appropriate pair of enzyme and
substrate was associated as an assembly and minimized with only
atoms in the side chains remaining unfixed. In some cases, the correct
rotamer for the side chain of the substrate residue had to be selected
empirically to avoid major clashes with the enzyme. As a result, the
substrate models were effectively docked with the peptidase models.
Amino Acid Sequence Alignments—Sequence alignments of the ma-
ture regions of the peptidases were prepared using Insight II software
from Molecular Simulations Inc. and empirically refined by hand. Sub-
sequently, to accommodate different colors, the alignment presented
here was prepared using MacVector 6.5.3 software (Oxford Molecular)
and edited manually to replicate the structural alignment generated
with Insight II.
Modeled Substrates—Homology models were constructed of aspartic
proteases complexed with the peptides KPIEF*FRL, FLSF*PTTK,
LVTL*AAHL, and LDKF*LASV (where * represents the characterized
or predicted scissile bond). FLSFPTTK, LVTLAAHL, and LDKFLASV
are octapeptides found in -chain of human Hb, as residues 33 to 40,
107 to 114, and 126 to 133, respectively. KPIEFFRL is a synthetic
peptide known to be a high affinity substrate for human cathepsin
D (23).
RESULTS
Substrate Subsite Binding Pockets—Fig. 1 presents the se-
quence alignments of the deduced mature enzyme amino acid
sequence of A. caninum cathepsin D-like protease, human ca-
thepsin D, S. japonicum cathepsin D, S. mansoni cathepsin D,
P. falciparum plasmepsin I, plasmepsin II, and mouse renin.
The three-dimensional structures of human cathepsin D, plas-
mepsin II, and mouse renin have been determined previously
(12, 13, 24, 25). The sequence alignment was based firstly on
structural alignment, with residues found in consensus regions
of secondary structure (-helix, -sheet) in human cathepsin D,
P. falciparum plasmepsin II, and mouse renin underlined. The
remaining sequences were aligned taking into account the po-
sitions of conserved Cys, Gly, and Pro residues, as well as
aromatic and hydrophobic residues in structurally conserved
regions. The 30 residues that constitute each subsite of the
various cathepsin D-like, Hb-degrading peptidases, including
P. vivax plasmepsin (1QS8) are listed in Table I, illustrating
not only the overall conservation of these residues but also
subsite differences among these peptidases. The allocation of
residues to the pockets differs somewhat from others reported
previously, particularly with respect to the S3 and S4 subsites
(8, 9, 12, 13), because it was assumed that the conformation of
the inhibitor-complexed enzyme mimics that of its substrate-
bound form. Profiles 3D analysis (22) of the molecular models
indicated a high probability of correct folding, with very few
residues defined as being misfolded (not shown).
Cleavage of Hemoglobin—The cleavage of mammalian Hb
by human cathepsin D has been reported recently (11), as
have the cleavage sites in human Hb for cathepsins D of S.
japonicum and S. mansoni (4). Hydrolysis of Hb by S. japoni-
cum cathepsin D involves a generally discrete set of cleavages
for the -chain, compared with cleavage sites for human
cathepsin D, whereas these two enzymes share most of the
same cleavage points for the -chain (Fig. 2) (4, 11). The
orthologous sequences at these known cathepsin D cleavage
sites for bovine, human, and canine Hb are also listed in Fig.
2, although this does not imply that those sites indicated for
other substrate species will be cleavage sites for that partic-
ular enzyme in every case. This scheme does not reflect the
relative importance of each cleavage site or their order. Fur-
ther, some sites in the Hb -chain are adjacent, including
Leu1052Leu106, Thr1082Leu109, and Leu1092Ala110; cleav-
age at any one of these would probably obviate cleavage at
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the vicinal sites. Perhaps the most striking of all these ca-
thepsin D cleavage sites is FLSF2PTTK (residues 33–40 of
the human Hb -chain), for schistosomal enzyme (4), because
a substrate with a proline residue at P1 appears to be rare or
even unique for a eukaryotic aspartic protease.
Molecular Models—Each of the protease and pro-
teasesubstrate complex models minimized to a plausible struc-
ture with no significant defects. However, for reasons of brevity
and clarity, much of the analysis and discussion presented here
focus on the cathepsin D-like protease from S. japonicum.
Profiles 3D analysis (19) of the model of this enzyme gave a
value of 151, compared with an overall self-compatibility score
of 151 and a lowest possible score of 68. This is a high figure,
indicating a high probability that the model is correct. The only
site of possible misfolding is the loop 46–54, which is well clear
of the substrate binding cleft. Fig. 3 shows the general conser-
vation of fold between the apoenzymes of human and S. japoni-
cum cathepsins D; side chains of residues that constitute the
subsite binding pockets are highlighted. To further investigate
the magnitude of sequence variation in the subsite binding
pockets and the associated implications for substrate affinities,
molecular models of human cathepsin D complexed with
KPIEF2FRL, and of S. japonicum cathepsin D with three
discrete octapeptides from human Hb, are presented in Fig. 4
(panels A, B, C, and D, respectively). Specific details of the
modeled complexes are provided below.
Human Cathepsin D Modeled with KPIEFFRL at Its Active
Site Cleft—KPIEFFRL is a high affinity substrate for recombi-
nant human cathepsin D (23). Lys at P5 is mostly exposed to
the solvent. Ala13 makes contact with -methylene of the P5
Lys. P4 Pro is mostly in hydrophobic contact with Leu236,
whereas Ile at P3 is predominantly in hydrophobic contact with
Thr118 (methyl) and Gln14 (-methylene). For Glu at P2, the
carboxyl forms a hydrogen bond with the hydroxyl group of
Ser80, and the -methylene contacts Thr227. However, because
Ser80 is known to hydrogen bond with the P2 NH of the inhib-
itor main chain (13), this is not certain. The P1 Phe makes
hydrophobic interactions with Phe104, Phe119, and Tyr78 of the
protease, and Phe at P1 makes hydrophobic interactions with
Ile313, Ile222, and Met302. Arg at P2 is mostly exposed to the
solvent, though there are minor contacts with the -methylene
of His77 and with Ile135. Leu at P3 makes hydrophobic contact
with Ile222 and Tyr198 (Fig. 4, panel A). The model explains why
KPIEFFRL is a high affinity substrate for human cathepsin D;
it makes numerous contacts with the active site of the
peptidase.
Modeled Complex of S. japonicum Cathepsin D with LVT-
LAAHL at Its Active Site Cleft—LVTLAAHL represents resi-
dues 107 to 114 of the -chain of human Hb. It is a cleavage site
for both human and schistosome cathepsins D (Fig. 2) (4, 11).
Leu at P4 has considerable hydrophobic contact with Met224.
Val at P3 has hydrophobic contacts with Val114 and Gln14,
whereas Thr P2 has hydrophobic contacts with Thr222. Leu at
P1 makes hydrophobic contacts with Tyr78 and Phe115, and P1
Ala makes hydrophobic contacts with Ile306 and Ile217. The Ala
at P2 makes weak contact with the -methylene of Ser36. With
the P3 His, the imidazole ring is mostly solvated, and the
epsilon methenyl makes contact with Ile217 and some contact
with Tyr194. Leu at P4 has some hydrophobic contact with
Ile131 (Fig. 4, panel B). Each of these interactions can also be
achieved with human cathepsin D/LVTLAAHL (not shown),
which explains why this is a cleavage site for both enzymes.
FIG. 1. Sequence alignment of amino acids of six aspartic proteases based on secondary structure and sequence homology. The
mature enzyme domains only of the proteases enzymes are shown. SJASP, the cathepsin D-like protease of the Asian blood fluke S. japonicum
(L41346); SMASP, the cathepsin D-like protease of the African blood fluke S. mansoni (U60995); HCATHD, human cathepsin D (P07339);
ACASP1, the cathepsin D-like protease of the hookworm A. caninum (U34888); PLAS1, plasmepsin I of the malaria parasite P. falciparum
(X75787); PLAS2, plasmepsin II of P. falciparum (L10740); and MRENIN, renin from the mouse (P06281). Residues that have side chains
participating in substrate binding pockets are indicated by their subsite numbers (S5-S4). The dyad of catalytic aspartic acids residues is indicated
with asterisks. The arrow indicates the position of loop 3 in human cathepsin D, the site of processing to a two-chain form (see Refs. 6 and 12). Black
boxes with white letters show identical residues, and gray boxes with black letters show chemically similar residues.
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Model of S. japonicum Cathepsin D with LDKFLASV at Its
Active Site Cleft—LDKFLASV represents residues 126 to 133
of the -chain of human Hb. S. japonicum cathepsin D cleaves
at this site, whereas the human enzyme does not (Fig. 2) (4, 11).
In the model (Fig. 4, panel C), Leu at P4 makes extensive
hydrophobic contacts with Met224, Asp at P3 hydrogen bonds to
Gln14, and Lys at P2 makes hydrophobic contacts with Thr222.
Further, the epsilon amino group of the P2 Lys hydrogen bonds
to main chain at residues Leu225 and Ala226. The latter is not
possible with human cathepsin D (not shown), perhaps explain-
ing why this site is not cleaved by human cathepsin D. The Phe
at P1 makes hydrophobic interactions with Tyr78, Phe115, and
Phe120 of the schistosome peptidase. Leu at P1 has extensive
hydrophobic interactions with Ile306. The Ala at P2 has weak
contact with the -methylene of Ser36 and Arg77. Arg77 has a
different conformation from that in panel B. The Ser at P3 has
a minor contact with Tyr194, whereas the P4 Val has consid-
erable hydrophobic contact with Leu131.
Model of S. japonicum Cathepsin D with FLSFPTTK at Its
Active Site Cleft—FLSFPTTK represents residues 33 to 40 of
the -chain of human Hb. As with LDKFLASV (above), it is a
cleavage site for schistosome but not human cathepsin D (Fig.
2). Again, this is an unusual cleavage site, in that a PI Pro
represents an ostensibly rare substrate preference for a eu-
karyotic aspartic peptidase. As shown in Fig. 4, panel D, Phe at
P4 has hydrophobic contacts with Met224 and Ile295, and Leu at
P3 has hydrophobic contacts with Val114. The P2 Ser hydrogen
bonds to Thr222 through the hydroxyls. The Phe at P1 contacts
methyl groups of Val114 and Thr80 (these contacts are not
possible with the human enzyme). The P1 Phe also contacts
Tyr78 and Phe120, but not the Phe116, of the S1 pocket. Back-
bone atom locations in P2, P1, and P1 differ considerably from
those in modeled complexes of S. japonicum cathepsin D with
LVTLAAHL or LDKFLASV, described above. The Pro P1 has
weak hydrophobic contacts with Ile306 and possibly Thr222 but
does not contact the Ile217 at S1/S3. The Thr P2 makes weak
contacts with Ser36 but is mostly solvent-exposed. The Thr at
P3 contacts Ile217 and Tyr194 but would not contact Ile217 if the
P1 residue were larger. The Lys at P4 is mostly solvent-
exposed but has some hydrophobic contact with Leu131 (Fig. 4,
panel D). An additional feature is noteworthy, if enigmatic; the
conformation of Arg77 of the S2 pocket (Table I) differs in each
of the three S. japonicum cathepsin D models presented here
(Fig. 4, panels B, C, and D), yet none of the P2 residues
apparently makes meaningful contact with Arg77.
Plasmepsins—Plasmepsins I and II are located in the diges-
tive vacuole of intraerythrocytic stages of the malaria parasite,
P. falciparum, where they function in the proteolysis of human
Hb (20, 21). The crystal structures of plasmepsin II (24) and
proplasmepsin II (25) have been reported, and the crystal
structure of a plasmepsin of P. vivax is available (1QS8). The
plasmepsins are too dissimilar to human cathepsin D to be
designated cathepsin D-like enzymes, as can be seen in Fig. 1.
However, all of the parasite and mammalian enzymes exam-
ined here, including the plasmepsins, belong to the same fam-
ily, family A1 of the pepsin clan (clan AA), according to the
phylogeny and nomenclature of Barrett et al. (5). This struc-
ture-based sequence alignment (Fig. 1) showed 33% identity of
TABLE I
Residues that constitute the subsite binding pockets, S5 to S4, of human cathepsin D (HuCathD), cathepsins D from Schistosoma japonicum
and S. mansoni (abbreviated here as Sj and Sm CathD, respectively), and Ancylostoma caninum (AcASP-1), plasmepsins I and II of
Plasmodium falciparum (Pf), and plasmepsin from P. vivax (Pv), as determined by three-dimensional homology modeling
Residues that differ between the parasite enzymes when compared with human cathepsin D are shown in bold. Catalytic dyad aspartic acid
residues are annotated with an asterisk.
Subsite HuCathD Sj/Sm CathD AcASP-1
Pf
plasmepsin
I/II
Pv
plasmepsin
S5 Ala13 Ala13/Ala13 Ala11 Ile14/Val14 Ile13
S3 Gln14 Gln14/Gln14 Gln13 Met15/Met15 Met15
S1 Val31 Val31/Val31 Ile30 Ile32/Ile32 Ile32
Catalytic Asp33* Asp33*/Asp33* Asp32* Asp34*/Asp34* Asp34*
S1 Gly35 Gly35/Gly35 Gly34 Gly36/Gly36 Gly36
S2 Ser36 Ser36/Ser36 Ser35 Ser37/Ser37 Ser37
S2 Ile76 Ile76/Val76 Ile
75
Met75/Met75 Ile75
S2 His77 Arg77/His77 Gln76 Asn76/Asn76 Thr76
S1 Tyr78 Tyr78/Tyr78 Tyr77 Tyr77/Tyr77 Tyr77
S4 Ser80 Thr80/Thr80 Thr79 Ser79/Ser79 Ser79
S3 Ile124 Leu113/Leu113 Leu112 Pro113/Pro113 Pro113
S3/S1 Thr125 Val114/Val114 Thr113 Thr114/Ala114 Ile114
S1 Phe126 Phe115/Phe115 Phe114 Tyr115/Tyr115 Tyr115
S4 Ala129 Ala118/Ala118 Ala117 Ser118/Gly118 Val118
S3/S1 Phe131 Phe120/Phe120 Phe119 Phe120/Phe120 Phe120
S2 Ile134 Ile123/Ile123 Ile122 Ile123/Ile123 Ile123
S4 Ile142 Leu131/Ile131 Ile130 Leu131/Leu131 Leu131
S2 Val144 Val133/Val133 Val132 Ile133/Ile133 Ile133
S3 Tyr205 Tyr194/Tyr194 Tyr193 Tyr192/Tyr192 Tyr197
S1/S3 Ile229 Ile217/Ile217 Ile220 Ile212/Ile212 Ile212
Catalytic Asp231* Asp219*/Asp219* Asp222* Asp214*/Asp214* Asp214*
S1 Gly233 Gly221/Gly221 Gly224 Gly216/Gly216 Gly216
S2 Thr234 Thr222/Thr222 Thr225 Thr217/Thr217 Thr217
S4 Leu236 Met224/Met224 Leu227 Ala219/Ser219 Thr218
S2 Val238 Ala226/Ala226 Ala229 Thr221/Thr221 Thr221
S4 Met307 Ile295/Met295 Met298 Ile290/Ile290 Leu290
S1/S2 Met309 Met297/Leu297 Met300 Leu292/Val292 Val292
S1/S3 Ile311 Leu299/Leu299 Phe302 Phe294/Leu294 Ile294
S3 Pro312 Pro300/Pro300 Pro303 Pro295/Asn295 Asp295
S1 Ile320 Ile308/Ile308 Ile311 Ile300/Ile300 Ile300
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plasmepsin II with human cathepsin D and 31% for plasmepsin
I. Blastp analysis revealed that the mature form of the P. vivax
plasmepsin (1QS8) is 31% identical to human cathepsin D and
70% identical to plasmepsin II of P. falciparum. In all three
plasmepsins examined here, about half of the substrate binding
residues of human cathepsin D are conserved (Table I). Plas-
mepsin I of P. falciparum cleaves the human Hb -chain at
residue 33 (ERMF2LSFP), residue 46 (FPHF2DLSH), and
residue 98 (VNFK2LLSH) and the -chain at residues 31
(LGRL2LVVY), 41 (TQRF2FESF), and 129 (VQAA2YQKV)
(2). P. falciparum plasmepsin II cleaves the human Hb -chain
at residues 33 (ERMF2LSFP), 108 (LLVT2LAAH), and 136
(STVL2TSKY) and the -chain at residue 32 (GRLL2VVYP)
(2). These differences in cleavage sites may be the reason for
having (at least) two plasmepsins; the combination of cleavages
by both plasmepsins may deliver Hb fragments small enough
for further processing by other peptidases. The oligopeptide
Ala-Leu-Glu-Arg-Thr-Phe2Phe-Ser-Phe-Pro-Thr has been
proposed as an ideal plasmepsin II substrate, based on the
ERMF2LSFP cleavage site (24).
As shown in Table I, the S4, S3, S2, S1, and S2 subsites of
the malarial plasmepsins differ considerably from those of the
human, schistosome, and hookworm cathepsins D, possibly
explaining the fewer Hb cleavage sites for the P. falciparum
plasmepsins. The presence of Ala219 (instead of Leu or Met,
present in the human, schistosome, and hookworm cathepsins
D) ensures a more open S4 pocket, which would accommodate
the binding by large hydrophobic residues such as Phe. It
would also allow binding by hydrophilic and charged residues,
such as Glu, although this is not evident from the known Hb
cleavage sites (2). However, the P. falciparum plasmepsins I
and II and the P. vivax plasmepsin all retain a Ser equivalent
to Ser80 of human cathepsin D (Table I), which suggests that
they would have a similar P2 specificity for Glu residues. An-
other similarity with the human enzyme is the presence of an
equivalent residue to Thr125 in the S3/S1 pockets (Thr114 in
plasmepsin I) (Table I), which would prevent plasmepsin I from
cleaving FLSFPTTK (not shown), a site cleaved by the schis-
tosome cathepsins D (see Fig. 2 and Fig. 4D) but not by the
human cathepsin D or P. falciparum plasmepsins I and II
(2, 11).
DISCUSSION
Hemoglobin-degrading enzymes of hematophagous parasites
are being targeted for the rational development of novel anti-
parasitic compounds (26, 27). Given that Hb is the natural
substrate of these enzymes, comparison of their cleavage sites
in the molecule with the cleavage site profile of homologous
mammalian-host enzymes, such as human cathepsin D, is
likely to provide specific leads that could be exploited in inhib-
itor design. However, information on the Hb-cleavage patterns
for human schistosomes has not been available until recently.
Accordingly, by focusing here on the specific substrate cleavage
patterns known for schistosome cathepsin D (4) and human
cathepsin D (11), we undertook a molecular modeling analysis
of some representative shared and discrete cleavage sites. This
involved the docking of octapeptides representing the P4-P4
residues of Hb cleavage sites that were either common to both
schistosome and human cathepsins D or cleaved by one but not
the other.
Using the crystal structures of human cathepsin D com-
plexed with pepstatin and mouse renin complexed with CH-66
as guides for the models, 30 residues could be identified as
major contributors to substrate or inhibitor binding in the
panel of target parasite and mammalian aspartic proteases
(Table I). Eight of these catalytic subsite residues differed
between human and S. japonicum cathepsins D. Such an os-
tensibly minor difference between these two enzymes raised
the question as to why they do not cleave the - and -chains of
Hb at exactly the same sites; of the 13 cleavage sites reported
for both the mammalian (11) and S. japonicum cathepsin D (4),
only six are shared (Fig. 2). As depicted in Fig. 4, homology
models of the S. japonicum and/or human enzyme complexed
with four informative octapeptides allowed examination of
their subsite binding pockets. Whereas other, usually hydro-
philic, residues can occur in any of the peptide subsites, their
side chains do not interact with the enzyme. Glycine residues
can also be found. Further, the exact nature of the Hb cleavage
sites would depend on the order of cleavage, because an adja-
cent site may obscure its neighbor.
The S4 subsite is essentially a hydrophobic pocket. In human
cathepsin D, it comprises Leu236 and Met307. These are re-
placed with Met or Ile in the S. japonicum and S. mansoni
cathepsins D, changes that would have minimal influence on
the specificity of this pocket. Residues preferred by human
cathepsin D at P4 include Leu, Val, Thr, Pro, and Ala (8–11).
The S3 pocket comprises Gln14, Ile124, Thr125, Ala129, and
Phe131, and Met, Ile, Ser, and Thr are preferred P3 residues. S3
is both a hydrophilic and a hydrophobic pocket, with hydro-
philic residues binding to the Gln14 side chain and hydrophobic
residues binding to the remainder. Longer hydrophobic side
chains can reach into the pocket as far as Ala129 and possibly
FIG. 2. Known and predicted cleavage sites for S. japonicum
and human cathepsins D in mammalian (human, bovine, and
canine) hemoglobin. Peptide bond cleaved after residue indicated.
Residues marked with underlines show the presence of substitutions in
orthologous amino acids. The hemoglobin sequences were obtained from
the public domain; the data base accession numbers for the bovine
hemoglobin - and - chains are P01966 and P022070, for the canine
hemoglobin - and -chains they are P01952 and P02056, and for the
human hemoglobin - and -chains they are NP000508 and NP000509.
Some of the information for this figure was obtained from Refs. 4
and 11.
Substrate Specificity of Parasite Hemoglobinases38848
 at UQ Library on September 1, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Phe131. Ile124 is probably too distant to be normally involved in
binding, although it could be exploited in inhibitor design.
Changing Thr125 to a Val has little effect on the S3 pocket,
because it is the methyl moiety of Thr125, rather than the
hydroxyl, that faces this pocket.
The S2 subsite of human cathepsin D comprises Ser80,
Thr234, Val238, and Met309 (Table I) and exhibits a preference
for Glu, Ile, Val, Ala, or Phe at P2 (8–11). Shorter residues,
such as Val and Ala, bind to Thr234, with longer residues such
as Met, Ile, or Phe also binding to Val238 and possibly Met309.
The major exception is a P2 Glu, which hydrogen bonds to
Ser80, in what is known in aspartic proteases as one of the
“flaps” that close over the active site when a peptide is bound
(28). As has been demonstrated with the equivalent mouse
reninCH-66 complex (13), the hydroxyl group of Ser80 normally
hydrogen bonds with the P2 amino group of the inhibitor. A
putative hydrogen bond with the P2 Glu side chain would have
to be a novel feature, unless the Ser hydroxyl can share two
hydrogen bonds. This provides the likely reason why human
cathepsin D cleaves AAEY2GAEA (residues 21–28, -chain of
Hb) whereas S. japonicum cathepsin D does not (Fig. 2), par-
ticularly as the P1 Gly does not contribute to substrate bind-
ing. Replacing Ser80 with Thr, as occurs in the schistosome
enzyme (Table I), weakens this hydrogen bond, because the
hydroxyl of the Thr adopts a rotamer slightly different from
that in Ser. This modifies the P1 pocket, because the methyl
group of the Thr now intrudes. Alanine (Ala226) instead of
Val238 (Table I) would open up the distal end of the S2 subsite,
but this would affect only longer hydrophilic residues, such as
lysine, at the P2 position. These models of S. japonicum ca-
thepsin D indicate that the epsilon-amino group of a P2 Lys
(e.g. see Fig. 4C) would be able to hydrogen bond to the carbonyl
oxygen of the Ile residue immediately preceding the Ala. This
option would be blocked with human cathepsin D, providing
the likely explanation why S. japonicum cathepsin D, but not
the human enzyme, cleaves LDKF2LASV (residues 126–133,
Hb -chain). Note that a P2 Arg is possible for human cathep-
sin D, as can be seen with several of the mammalian Hb
cleavage sites (Fig. 2), because the guanidino group of Arg can
be considerably solvated (more so than Lys), thereby stabilizing
the enzymesubstrate complex. The larger S2 site in the Schis-
tosoma enzyme probably accounts for its cleavage of
ERMF2LSFP (Hb -chain, residues 30–37) with Met at the
P2 position. Human cathepsin D cleaves the adjacent
LERM2FLSF site. The sole Hb -chain cleavage site common
to both human and S. japonicum cathepsins D is LLVT2LAAH
(-chain residues 106–113) (Fig. 2). This contains residues that
both proteases can readily accommodate, including valine at
P2. However, the adjacent LVTL2AAHL is a cleavage site only
for S. japonicum cathepsin D.
The S1 subsite in human cathepsin D comprises Val31, Asp33,
Tyr78, Thr125, Phe126, Ile229, Asp231, and Gly233 and exhibits a
preference for Leu, Tyr, Phe, or Ile as P1 residues. Clearly, this
is a very hydrophobic subsite that can accommodate the side
chains of Leu and Phe. The two changes, Ser80 to Thr and
Thr125 to Val, observed with both Schistosoma cathepsins D,
render that side of the S1 pocket even more hydrophobic than
that of human cathepsin D. This becomes important with the
schistosomal cathepsin D cleavage of FLSF2PTTK. The P1
proline residue readily fits into the S1 subsite. However, the
change in the peptide backbone affects the location and confor-
mation of the Phe at P1. With the S. japonicum cathepsin D,
Phe at P1 can bind to the methyl groups of Thr80 and Val114.
With human cathepsin D, by contrast, the hydrophilic hydroxyl
of Thr125 impedes the binding of a P1 Phe when proline is at
P1. These findings indicate that the octapeptide FLSFPTTK
could be a useful lead for developing a specific inhibitor of
schistosomal cathepsin D. Development of inhibitors of HIV
protease followed the discovery of a similar preference by HIV,
type I retropepsin for Pro at P1 (29, 30).
The S1 subsite of human cathepsin D comprises Gly35,
Asp231, Met309, Ile311, and Ile320, and its preferences include
Leu, Val, Ala, and Phe at P1 (8–11). Phe side chains at P1
adopt one of two conformations. The Phe rotamer found with
human and Schistosoma cathepsins D faces toward the S2
pocket, with the S-methyl of Met309 (which arises in the S2
subsite) contacting the -methylene of the Phe. With the hook-
worm cathepsin D, which has a S1 Phe instead of Ile311, the
P1 Phe adopts a different rotamer, it faces the S3 subsite,
because it is sterically hindered from facing toward Met309.
This conformation is also adopted for a P1 Leu for any of the
enzymes, because a P1 Leu cannot reach as far as Met309.
Consequently, the side chain of the P1 Phe makes more con-
tacts with the enzyme.
The S2 subsite of human cathepsin D comprises Ser36, Ile76,
His77, Ile134, Ile142, and Val144 and exhibits a preference for
FIG. 3. Stereo view of molecular
model of S. japonicum cathepsin D
(panel A) based on the crystal struc-
ture of human cathepsin D (1LYA)
(panel B). -Sheets are shown as green
ribbons, whereas loops and -helices are
shown as magenta carbon traces. Side
chains of residues that constitute the sub-
site binding pockets are highlighted. The
model was generated using the Swiss
Model server and viewed in Swiss
PDBViewer.
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Lys, Arg, Glu, or His at P2. As with the S3 subsite, this pocket
should accommodate hydrophobic and hydrophilic side chains,
although P2 hydrophobics are not common (8–11). These mod-
els suggest that the functional ends of long basic P2 residues
(Lys and Arg) are mostly exposed to the solvent but that
shorter hydrophilic side chains, such as those of Glu and Asp,
would be able to hydrogen bond with Ser36 or possibly with
His77. Replacement of His77 with either Arg or Gln will change
the order of preferred residues at P2 but not the overall mix.
An Arg at this position may promote the possibility of a P2 Glu
by forming a salt bridge, whereas Gln at this position may
promote the possibility of a Gln at P2 through mutual hydro-
gen bonding. Hydrophobic residues such as valine can bind to
Val144.
The S3 subsite residues of human cathepsin D are Tyr205,
Ile311, and Pro312, and preferences at P3 include Leu, Lys, Val,
Tyr, and Thr (8–11). This is another predominantly hydropho-
bic pocket. Ile311 is variable, affecting both the S1 and the S3
pockets, but this would have little influence on subsite speci-
ficity. The S4 pocket is composed of Ile142 in human cathepsin
D, and its P4 preferences include Ala, Ser, Val, Lys, Phe, and
Tyr. Most of these P4 amino acids would be exposed to the
solvent, but smaller hydrophobic residues such as Ala or Val
can bind to Ile142. Mutating the Ile142 to Leu in S. japonicum
cathepsin D (Ile131; see Table I) should have minimal effect on
subsite specificity.
It is clear that the differences in Hb cleavage by the pro-
teases examined here reflect subtle yet significant differences
in their substrate binding pockets. Development of selective
inhibitors of these parasite aspartic proteases as novel anti-
infective agents will depend on defining these differences and
deriving compounds that exploit one or (preferably) several of
them. From an evolutionary perspective, it is straightforward
to conceptualize how mutations in Hb genes would lead to
amino acid substitutions in their products and how the cumu-
lative effect of such substitutions could then reduce the effi-
ciency of the cognate hemoglobinases of the hematophagous
parasite, delivering a selective advantage to the host by reduc-
ing the viability or virulence of the parasite. Moreover, as
speculated previously (31), the compatibility between an Hb-
degrading enzyme of the parasite and the Hb of its mammalian
hosts (Fig. 2) is likely to be a critical factor in determining its
host range, i.e. host specificity. In this regard, it is notable that
plasmepsin II has a lower affinity for fetal than for adult Hb,
which contributes to the innate resistance of human neonates
to malaria (32).
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